Report Description

The global hand, foot, and mouth disease treatment market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of viral infections, and extensive research and development are propelling the growth of the market, globally. Hand, foot, and mouth disease also abbreviated as HFMD is a contagious disease which is caused by enterovirus genus majorly Coxsackievirus A16 and enterovirus A71. These viruses are majorly detected in children below age 10 and is usually spread through skin-to-skin contact, airborne respiratory droplets or by saliva. The other factors supporting the market’s growth are, the increasing government investments on R&D activities, growing footprint of pharmaceutical manufacturers, developed healthcare infrastructure, rising awareness among the masses, and technological advancements. Also, ease in FDA approvals for hand, foot, and mouth disease (HFMD) drugs in clinical trial phase is further projected to drive the growth of hand, foot, and mouth disease treatment market.

High Prevalence of Viral Infection

Viral infections are very common in children below age 10 as they have very low immunity, and they often tend to put their hands in mouth. Hand, foot, and mouth disease (HFMD) is caused by a virus from the Enterovirus genus, most commonly the coxsackievirus.  These viruses are transmitted from infected person to other. Owing to the large patient pool due to HFMD, the demand for hand, foot and mouth disease treatment is upsurging. Moreover, growth of the health care industry due to the growing incidences of viruses across the globe is facilitating the market growth. For instance, from 2013−2019, 15,316,710 probable cases of HFMD were reported. Out of these, 787,197 (5·1%) were laboratory confirmed and 76,982 (0·5%) were severe.

Growing Awareness and Research

Over the past few years, increase in awareness among masses about the hand, foot and mouth diseases is seen. Various awareness programs are initiated by governments of different nations, which are propelling the growth of the market. Hand, foot, and mouth disease is widespread pediatric disease which occurs in children under the age of 5. Owing to the rise in number of patients suffering from HFMD, demand for the drug discovery research is rising. This, in turn, propels the market growth. For instance, according to Iranian Journal of Public Health, a study conducted from 2008 to 2015 revealed the incidence of HFMD grew rapidly from 86.59/100,000 in 2009 to 203.16/100,000 in 2014. Moreover, heavy investments by governments and market players on R&D activities and clinical trials, are bolstering the market growth.


Download Free Sample Report

Market Segmentation

The global hand, foot, and mouth disease treatment market is segmented into drug type, route of administration, distribution channel, and company. Based on drug type, the market is divided into pain relievers, non-steroidal anti-inflammatory drugs, and nucleoside analogue antivirals. Based on route of administration, the market is divided into topical, oral, and intravenous. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising research and development activities in the country.

Market Players

Johnson & Johnson, GlaxoSmithKline plc., Emergex Vaccines Holdings Ltd, Takeda Pharmaceutical Co Ltd, CJ HealthCare Corp., and Adimmune Corp are some of the leading companies operating in the market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends

Segments covered

·         Drug Type

·         Route of Administration

·         Distribution Channel

·         Company

Regional scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa

Key companies profiled

Johnson & Johnson, GlaxoSmithKline plc., Emergex Vaccines Holdings Ltd, Takeda Pharmaceutical Co Ltd, CJ HealthCare Corp., and Adimmune Corp

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, global hand, foot, and mouth disease treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Hand, Foot, and Mouth Disease Treatment Market, By Drug Type:

    • Pain Relievers
    • Non-Steroidal Anti-inflammatory Drugs
    • Nucleoside Analogue Antivirals

·         Hand, Foot, and Mouth Disease Treatment Market, By Route of Administration:

    • Topical
    • Oral
    • Intravenous

·         Hand, Foot, and Mouth Disease Treatment Market, By Distribution Channel:

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

·         Hand, Foot, and Mouth Disease Treatment Market, By Region:

    • North America
      • United States
      • Canada
      • Mexico
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Europe & CIS
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Hand, Foot, and Mouth Disease Treatment Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Hand, Foot, and Mouth Disease Treatment Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Hand, Foot, and Mouth Disease Treatment Market

4.    Voice of Customer

5.    Executive Summary

6.    Clinical Trial Analysis

7.    Global Hand, Foot, and Mouth Disease Treatment Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals)

7.2.2.     By Route of Administration (Topical, Oral, Intravenous)

7.2.3.     By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

7.2.4.     By Company (2021)

7.2.5.     By Region

7.3.  Market Map

8.    North America Hand, Foot, and Mouth Disease Treatment Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Drug Type

8.2.2.     By Route of Administration

8.2.3.     By Distribution Channel

8.2.4.     By Country

8.3.  North America: Country Analysis

8.3.1.     United States Hand, Foot, and Mouth Disease Treatment Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Drug Type

8.3.1.2.2.             By Route of Administration

8.3.1.2.3.             By Distribution Channel

8.3.2.     Mexico Hand, Foot, and Mouth Disease Treatment Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Drug Type

8.3.2.2.2.             By Route of Administration

8.3.2.2.3.             By Distribution Channel

8.3.3.     Canada Hand, Foot, and Mouth Disease Treatment Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Drug Type

8.3.3.2.2.             By Route of Administration

8.3.3.2.3.             By Distribution Channel

9.    Europe Hand, Foot, and Mouth Disease Treatment Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Drug Type

9.2.2.     By Route of Administration

9.2.3.     By Distribution Channel

9.2.4.     By Country

9.3.  Europe: Country Analysis

9.3.1.     France Hand, Foot, and Mouth Disease Treatment Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Drug Type

9.3.1.2.2.             By Route of Administration

9.3.1.2.3.             By Distribution Channel

9.3.2.     Germany Hand, Foot, and Mouth Disease Treatment Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Drug Type

9.3.2.2.2.             By Route of Administration

9.3.2.2.3.             By Distribution Channel

9.3.3.     United Kingdom Hand, Foot, and Mouth Disease Treatment Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Drug Type

9.3.3.2.2.             By Route of Administration

9.3.3.2.3.             By Distribution Channel

9.3.4.     Italy Hand, Foot, and Mouth Disease Treatment Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Drug Type

9.3.4.2.2.             By Route of Administration

9.3.4.2.3.             By Distribution Channel

9.3.5.     Spain Hand, Foot, and Mouth Disease Treatment Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Drug Type

9.3.5.2.2.             By Route of Administration

9.3.5.2.3.             By Distribution Channel

10.  Asia-Pacific Hand, Foot, and Mouth Disease Treatment Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Drug Type

10.2.2.  By Route of Administration

10.2.3.  By Distribution Channel

10.2.4.  By Country

10.3.              Asia-Pacific: Country Analysis

10.3.1.  China Hand, Foot, and Mouth Disease Treatment Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Drug Type

10.3.1.2.2.           By Route of Administration

10.3.1.2.3.           By Distribution Channel

10.3.2.  India Hand, Foot, and Mouth Disease Treatment Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Drug Type

10.3.2.2.2.           By Route of Administration

10.3.2.2.3.           By Distribution Channel

10.3.3.  Japan Hand, Foot, and Mouth Disease Treatment Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Drug Type

10.3.3.2.2.           By Route of Administration

10.3.3.2.3.           By Distribution Channel

10.3.4.  South Korea Hand, Foot, and Mouth Disease Treatment Market Outlook

10.3.4.1.      Market Size & Forecast

10.3.4.1.1.           By Value

10.3.4.2.      Market Share & Forecast

10.3.4.2.1.           By Drug Type

10.3.4.2.2.           By Route of Administration

10.3.4.2.3.           By Distribution Channel

10.3.5.  Australia Hand, Foot, and Mouth Disease Treatment Market Outlook

10.3.5.1.      Market Size & Forecast

10.3.5.1.1.           By Value

10.3.5.2.      Market Share & Forecast

10.3.5.2.1.           By Drug Type

10.3.5.2.2.           By Route of Administration

10.3.5.2.3.           By Distribution Channel

11.  South America Hand, Foot, and Mouth Disease Treatment Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Drug Type

11.2.2.  By Route of Administration

11.2.3.  By Distribution Channel

11.2.4.  By Country

11.3.              South America: Country Analysis

11.3.1.  Brazil Hand, Foot, and Mouth Disease Treatment Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Drug Type

11.3.1.2.2.           By Route of Administration

11.3.1.2.3.           By Distribution Channel

11.3.2.  Argentina Hand, Foot, and Mouth Disease Treatment Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Drug Type

11.3.2.2.2.           By Route of Administration

11.3.2.2.3.           By Distribution Channel

11.3.3.  Colombia Hand, Foot, and Mouth Disease Treatment Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Drug Type

11.3.3.2.2.           By Route of Administration

11.3.3.2.3.           By Distribution Channel

12.  Middle East and Africa Hand, Foot, and Mouth Disease Treatment Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Drug Type

12.2.2.  By Route of Administration

12.2.3.  By Distribution Channel

12.2.4.  By Country

12.3.              MEA: Country Analysis

12.3.1.  South Africa Hand, Foot, and Mouth Disease Treatment Market Outlook

12.3.1.1.      Market Size & Forecast

12.3.1.1.1.           By Value

12.3.1.2.      Market Share & Forecast

12.3.1.2.1.           By Drug Type

12.3.1.2.2.           By Route of Administration

12.3.1.2.3.           By Distribution Channel

12.3.2.  Saudi Arabia Hand, Foot, and Mouth Disease Treatment Market Outlook

12.3.2.1.      Market Size & Forecast

12.3.2.1.1.           By Value

12.3.2.2.      Market Share & Forecast

12.3.2.2.1.           By Drug Type

12.3.2.2.2.           By Route of Administration

12.3.2.2.3.           By Distribution Channel

12.3.3.  UAE Hand, Foot, and Mouth Disease Treatment Market Outlook

12.3.3.1.      Market Size & Forecast

12.3.3.1.1.           By Value

12.3.3.2.      Market Share & Forecast

12.3.3.2.1.           By Drug Type

12.3.3.2.2.           By Route of Administration

12.3.3.2.3.           By Distribution Channel

13.  Market Dynamics

13.1.              Drivers

13.2.              Challenges

14.  Market Trends & Developments

15.  Competitive Landscape

15.1.              Johnson & Johnson

15.2.              GlaxoSmithKline plc.

15.3.              Emergex Vaccines Holdings Ltd

15.4.              Takeda Pharmaceutical Co Ltd

15.5.              CJ HealthCare Corp.

15.6.              Adimmune Corp

16.          Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Growing incidences of viral infectiona and anti-biotic infections, and extensive research and development are driving the demand for the global hand, foot, and mouth disease treatment market.

down-arrow

Johnson & Johnson, GlaxoSmithKline plc., Emergex Vaccines Holdings Ltd, Takeda Pharmaceutical Co Ltd, CJ HealthCare Corp., and Adimmune Corp are the key players operating in the global hand, foot, and mouth disease treatment market.

down-arrow

Risk of acquiring other diseases such as Reye syndrome on consumption of pain relief drugs such as Aspirin may likely hamper the growth of global hand, foot, and mouth disease treatment market.

down-arrow

The Global Hand, Foot, and Mouth Disease Treatment Market is segmented based on drug type, route of administration and distribution channel.

profile

Sakshi Bajaal

Business Consultant
Press Release

Hand, Foot, and Mouth Disease Treatment Market to be dominated by Growing Prevalence of Viral Infections through 2027

Sep, 2022

Growing incidence of viral infections and rising research and development activities to drive the hand, foot, and mouth disease treatment market in the forecast period, 2023-2027.